Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Trial Comparing The Efficacy Of Anidulafungin And Voriconazole In Combination To That Of Voriconazole Alone When Used For Primary Therapy Of Proven Or Probable Invasive Aspergillosis

NCT00531479 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00531479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00531479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Trial Comparing The Efficacy Of Anidulafungin And Voriconazole In Combination To That Of Voriconazole Alone When Used For Primary Therapy Of Proven Or Probable Invasive Aspergillosis
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2008
Completion date
May 31, 2011
Enrollment
459 (actual)
Sites
107

Conditions

As the registry lists them; a condition with its own page is linked.

aspergillosis